Neurotechnology
Technologies interfacing with the nervous system for medical and research applications
Market Overview
Current Market Size
$5.2B (2024)
Projected Market Size
$15B (2030) (2024-2030)
Description
Brain-computer interfaces, neural implants, neuroprosthetics
Key Technology Segments
Brain-Computer Interfaces
Direct communication between brain and external devices
Key Players
Investment Trends
Investment in neurotechnology has shown strong growth, with total funding reaching $3.2B in 2024.
Commercialization Pathways
Licensing
medium feasibilityNeurotech IP can be licensed to medical device companies.
Spinout
high feasibilityStrong investor interest in neurotechnology startups.
Partnership
high feasibilityPartnerships with medical device companies are common.
Regulatory Considerations
- •FDA approval
- •Medical device regulations
- •Ethical considerations
Frequently Asked Questions
What is the market size for neurotechnology?
The neurotechnology market is currently valued at $5.2B (2024) and is projected to reach $15B (2030) by 2030, representing a 22% CAGR growth rate.
What are the main commercialization pathways for neurotechnology?
The primary commercialization pathways include spinout, partnership. Spinouts are particularly viable given strong investor interest.
Which universities are leading in neurotechnology research?
Leading universities in neurotechnology include MIT, Stanford, UC Berkeley, and others. These institutions have strong research programs and commercialization track records in this area.
What are the key technology segments in neurotechnology?
Key technology segments include Brain-Computer Interfaces. These segments represent different areas of innovation and market opportunity within the broader neurotechnology category.
Leading Universities
MIT
75 spinouts • $45.2M revenue
Stanford
110 spinouts • $95.0M revenue
UC Berkeley
125 spinouts • $52.3M revenue
Harvard
85 spinouts • $62.0M revenue
Related Tools
Get Market Intelligence
Use Commercify to analyze market opportunities and build your commercialization strategy.
See plans & pricing